
LHDX
Healthcare · Healthcare Equipment & Supplies · $18.4M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2022
EPS trend, 90 days to now · -300.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 10, 2023 | Before the open | -0.40 | -0.33 | +17.5% |
| Nov 14, 2022 | After the close | -0.38 | -3.15 | -728.9% |
| Aug 15, 2022 | After the close | -0.34 | -0.54 | -58.8% |
| May 12, 2022 | After the close | -0.08 | 0.31 | +487.5% |
| Mar 10, 2022 | After the close | -0.55 | 0.01 | +101.8% |
| Nov 11, 2021 | After the close | -0.51 | -0.47 | +7.8% |
| Aug 12, 2021 | After the close | -0.32 | -0.38 | -18.8% |
| May 13, 2021 | After the close | -0.33 | -0.54 | -63.6% |
| Feb 5, 2021 | After the close | -0.80 | -1.86 | -134.0% |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.92 | — |
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services…